1887

Abstract

Blood-borne infections are a major cause of harm in individuals on haemodialysis (HD). In particular, knowledge about hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) status in HD patients is a major concern, since these infections may cause comorbidities in this setting. There is a paucity of data regarding this issue in Argentina.

The epidemiological surveillance of HBV, HCV, and HIV is a fundamental tool for planning and implementing health strategies in order to prevent and control viral transmission of these viral agents.

To determine the seroprevalence of HBV, HCV and HIV infections in HD patients in Buenos Aires, Argentina.

Seven hundred and forty-eight HD patients were included in a retrospective cross-sectional study. Serological assays were performed to determine HBV, HCV and HIV status. HBV HBsAg and anti-HBc IgG were analysed using AxSYM (samples before 2010) or the Architect Abbott system (samples since 2010), anti-HCV IgG testing was performed using the anti-HCV enzyme immunoassay AxSYM HCV V3.0 and ARCHITECT anti-HCV, while HIV was tested for using AxSYM HIV 1/2 gO and ARCHITECT HIV Ag/Ab Combination. HCV genotyping was carried out by phylogenetic analysis of the NS5B partial gene.

Infection with one of the viruses was detected in 31.1 % of patients [HBV in 82 (11.0 %), HCV in 179 (23.9 %) and HIV in 6 (0.8 %)]. Thirty-two (4.3 %) patients had 2 virus markers [27 (3.6 %) with HCV/HBV, 4 (0.5 %) with HCV/HIV and 1 (0.13 %) with HBV/HIV]. Finally, a single patient (0.13 %) presented all three markers. Time on dialysis was correlated with HCV but not with HBV infection. The HCV subtype distribution in HD patients was inverted with respect to that observed in the general population (HCV-1a 73.2 % and HCV-1b 26.8 % in HD vs HCV-1a 26.5 % and HCV-1b 73.5 % in the general population, <0.001).

Despite the implementation of universal precautionary biosafety standards for dialysis, infection with HBV and HCV continues to occur at very high rates in HD patients. The results emphasize the need to carry out proactive tasks for early diagnosis and treatment of infected individuals and to vaccinate those with non-protective antiHBs antibodies in order to reduce morbidity and mortality in HD patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001278
2020-11-12
2021-07-29
Loading full text...

Full text loading...

References

  1. Marinovich S, Lavorato C, Bisigniano L, Hansen D, Celia E et al. Registro Argentino de Diálisis Crónica SAN-INCUCAI 2017. Available from http://san.org.ar/2015/docs/registros/2018/REGISTRO_ARGENTINO_DIALISIS_CRONICA_2017_VERSION_COMPLETA.pdf. (5 July 2020, date last accessed); 2018
  2. Li PKT, Chow KM. Infectious complications in dialysis-epidemiology and outcomes. Nat Rev Nephrol 2011; 8:77–88 [View Article][PubMed]
    [Google Scholar]
  3. Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin Cases 2018; 6:589–599 [View Article][PubMed]
    [Google Scholar]
  4. Boyle SM, Lee DH, Wyatt CM. Hiv in the dialysis population: current issues and future directions. Semin Dial 2017; 30:430–437 [View Article][PubMed]
    [Google Scholar]
  5. Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: a systematic review and meta-analysis. World J Gastroenterol 2017; 23:151–166 [View Article][PubMed]
    [Google Scholar]
  6. Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int 2019; 95:939–947 [View Article][PubMed]
    [Google Scholar]
  7. Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin S et al. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 2017; 31:2035–2052 [View Article][PubMed]
    [Google Scholar]
  8. Chew KW, Bhattacharya D. Virologic and immunologic aspects of HIV-hepatitis C virus coinfection. AIDS 2016; 30:2395–2404 [View Article][PubMed]
    [Google Scholar]
  9. Ganesan M, Poluektova LY, Kharbanda KK, Osna NA. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World J Gastroenterol 2019; 25:398–410 [View Article][PubMed]
    [Google Scholar]
  10. Flichman DM, Blejer JL, Livellara BI, Re VE, Bartoli S et al. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Argentine blood donors. BMC Infect Dis 2014; 14:218 [View Article][PubMed]
    [Google Scholar]
  11. Valtuille R, Frankel F, Gómez F, Moretto H, Fay F et al. The role of transfusion-transmitted virus in patients undergoing hemodialysis. J Clin Gastroenterol 2002; 34:86–88 [View Article][PubMed]
    [Google Scholar]
  12. Gomez Gutierrez C, Chávez-Tapia NC, Ponciano-Rodríguez G, Uribe M, Méndez-Sánchez N. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America. Ann Hepatol 2015; 14:807–814 [View Article][PubMed]
    [Google Scholar]
  13. Salvatierra K, Florez H. Análisis del virus de la hepatitis C en pacientes en hemodiálisis. Infectio 2016; 3:130–137
    [Google Scholar]
  14. Neukam K, Ridruejo E, Perez P, Campos RH, Martínez AP et al. Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups. Eur J Clin Microbiol Infect Dis 2018; 37:247–254 [View Article][PubMed]
    [Google Scholar]
  15. Martínez AP, García G, Ridruejo E, Culasso AC, Pérez PS et al. Hepatitis C virus genotype 1 infection: prevalence of NS5A and NS5B resistance-associated substitutions in naïve patients from Argentina. J Med Virol 2019; 91:1970–1978 [View Article][PubMed]
    [Google Scholar]
  16. Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 2015; 32:268–274 [View Article][PubMed]
    [Google Scholar]
  17. Ronquist F, Teslenko M, van der Mark P, Ayres DL, Darling A et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol 2012; 61:539–542 [View Article][PubMed]
    [Google Scholar]
  18. Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology 2010; 15:137–145 [View Article][PubMed]
    [Google Scholar]
  19. Di Lello FA, Blejer J, Alter A, Bartoli S, Vargas F et al. Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination. Vaccine 2020; 38:2678–2682 [View Article][PubMed]
    [Google Scholar]
  20. Boletín 2019; Boletín sobre LAS hepatitis virales en La Argentina. http://www.msal.gob.ar/images/stories/bes/graficos/0000001592cnt-2019-10_boletin-hepatitis.pdf 5 July 2020
  21. Fernandez JL, Valtuille R, Hidalgo A, del Pino N, Lef L et al. Hepatitis G virus infection in hemodialysis patients and its relationship with hepatitis C virus infection. Am J Nephrol 2000; 20:380–384 [View Article][PubMed]
    [Google Scholar]
  22. Gaite LA, Marciano S, Galdame OA, Gadano AC. Hepatitis C in Argentina: epidemiology and treatment. Hepat Med 2014; 6:35–43 [View Article][PubMed]
    [Google Scholar]
  23. Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK. Hepatitis C in hemodialysis patients. World J Hepatol 2015; 7:548–558 [View Article][PubMed]
    [Google Scholar]
  24. Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS et al. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int 2011; 31 Suppl 2:18–29 [View Article][PubMed]
    [Google Scholar]
  25. Simmonds P. The origin of hepatitis C virus. Curr Top Microbiol Immunol 2013; 369:1–15 [View Article][PubMed]
    [Google Scholar]
  26. Ruta S, Cernescu C. Injecting drug use: a vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol 2015; 21:10811–10823 [View Article][PubMed]
    [Google Scholar]
  27. Culasso AC, Farías A, Di Lello FA, Golemba MD, V et al. Spreading of hepatitis C virus subtypes 1A and 1B through the central region of Argentina. Infect Genet Evol 2014; 26:32–40 [View Article][PubMed]
    [Google Scholar]
  28. Quarleri JF, Bolcic FM, Bouzas MB, Laufer N, Gómez Carrillo M et al. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors. Acta Gastroenterol Latinoam 2007; 37:76–83[PubMed]
    [Google Scholar]
  29. Bolcic F, Laufer N, Trinchero J, Jones LR, Quarleri J. A clustering phenomenon among HCV-1a strains among patients coinfected with HIV from Buenos Aires, Argentina. J Med Virol 2012; 84:570–581 [View Article][PubMed]
    [Google Scholar]
  30. Carobene M, Bolcic F, Farías MS, Quarleri J, Avila MM. HIV, HBV, and HCV molecular epidemiology among trans (transvestites, transsexuals, and transgender) sex workers in Argentina. J Med Virol 2014; 86:64–70 [View Article][PubMed]
    [Google Scholar]
  31. Di Lello FA, Farias A, Culasso AC, Pérez PS, Pisano MB et al. Changing epidemiology of HCV genotypes in region central of Argentina. Arch Virol 2015; 160:909–915
    [Google Scholar]
  32. Boletín sobre el VIH 2018; Sida E its en La Argentina. Available from. http://www.msal.gob.ar/images/stories/bes/graficos/0000001385cnt-2018-12-20_boletin-epidemiologico-vih-sida-its_n35.pdf 5 July 2020
  33. Besone F, Campodónico ME, Paez M, Acosta F, Spoletti MJ et al. Outbreak of fulminant hepatitis associated with a precore mutant HBV strain in hemodialysis patients. Hepatology 2005; 42:
    [Google Scholar]
  34. Chiaraviglio M, Bessone F, Lema S, Mantelo C, Ortiz M et al. Infección POR VHC en hemodializados. Análisis prospective de un brote agudo. Acta Gastroenterológica Latinoamericana 2017; 47:
    [Google Scholar]
  35. Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol 2015; 11:150–160 [View Article][PubMed]
    [Google Scholar]
  36. Diana NE, Naicker S. Update on current management of chronic kidney disease in patients with HIV infection. Int J Nephrol Renovasc Dis 2016; 9:223–234 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001278
Loading
/content/journal/jmm/10.1099/jmm.0.001278
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error